|
| 37860921 | Participant-guided development of bilingual genomic educational infographics for Electronic Medical Records and Genomics Phase IV study. | J Am Med Inform Assoc | 2024 |
| 36413430 | Pharmacogenomic Profiling of Pediatric Patients on Psychotropic Medications in an Emergency Department. | Pediatr Emerg Care | 2023 |
| 38036523 | Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease. | Nat Commun | 2023 |
| 35857814 | Personalizing Direct Oral Anticoagulant Therapy for a Diverse Population: Role of Race, Kidney Function, Drug Interactions, and Pharmacogenetics. | Clin Pharmacol Ther | 2023 |
| 37016935 | Hypertension severity, apparent treatment resistant hypertension and hyperuricemia in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. | J Hypertens | 2023 |
| 37246632 | Education and electronic medical records and genomics network, challenges, and lessons learned from a large-scale clinical trial using polygenic risk scores. | Genet Med | 2023 |
| 36856778 | Does genetic testing offer utility as a supplement to traditional family health history intake for inherited disease risk? | Fam Pract | 2023 |
| 36621880 | Returning integrated genomic risk and clinical recommendations: The eMERGE study. | Genet Med | 2023 |
| 36540998 | Quantifying factors that affect polygenic risk score performance across diverse ancestries and age groups for body mass index. | Pac Symp Biocomput | 2023 |
| 36540997 | Predictive models for abdominal aortic aneurysms using polygenic scores and PheWAS-derived risk factors. | Pac Symp Biocomput | 2023 |
| 36760155 | Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis. | Clin Transl Sci | 2023 |
| 34562070 | Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy. | Clin Transl Sci | 2022 |
| 35710995 | Genome-wide polygenic score to predict chronic kidney disease across ancestries. | Nat Med | 2022 |
| 35765100 | Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations. | Genome Med | 2022 |
| 35568931 | Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy. | Implement Sci Commun | 2022 |
| 36506510 | Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients. | Front Pharmacol | 2022 |
| 36250097 | SMOC2 gene interacts with APOL1 in the development of end-stage kidney disease: A genome-wide association study. | Front Med (Lausanne) | 2022 |
| 36073636 | Risk of Postdischarge Bleeding From Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Among US Black and White Adults. | J Am Heart Assoc | 2022 |
| 36018758 | Arachidonate 5-lipoxygenase is essential for biosynthesis of specialized pro-resolving mediators and cardiac repair in heart failure. | Am J Physiol Heart Circ Physiol | 2022 |
| 35886043 | Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study. | Genes (Basel) | 2022 |
| 35100591 | APOL1 Risk Variants Associated with Serum Albumin in a Population-Based Cohort Study. | Am J Nephrol | 2022 |
| 35156424 | <i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings. | J Am Heart Assoc | 2022 |
| 35034351 | Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update. | Clin Pharmacol Ther | 2022 |
| 35108398 | Warfarin Dosing in Patients With CYP2C9*5 Variant Alleles. | Clin Pharmacol Ther | 2022 |
| 32897581 | Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention. | Clin Pharmacol Ther | 2021 |
| 33667441 | Outcomes of Individuals With and Without Heart Failure Presenting With Acute Coronary Syndrome. | Am J Cardiol | 2021 |
| 34992631 | Genetic Contributors of Incident Stroke in 10,700 African Americans With Hypertension: A Meta-Analysis From the Genetics of Hypertension Associated Treatments and Reasons for Geographic and Racial Differences in Stroke Studies. | Front Genet | 2021 |
| 34670396 | Genotype-Guided P2Y<sub>12</sub> Inhibitor Therapy After Percutaneous Coronary Intervention: A Bayesian Analysis. | Circ Genom Precis Med | 2021 |
| 34464454 | Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment-Resistant Epilepsy. | Clin Pharmacol Ther | 2021 |
| 34121327 | Evaluation of population-level pharmacogenetic actionability in Alabama. | Clin Transl Sci | 2021 |
| 34233023 | Translational Pharmacogenomics: Discovery, Evidence Synthesis and Delivery of Race-Conscious Medicine. | Clin Pharmacol Ther | 2021 |
| 33428770 | Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems. | Clin Pharmacol Ther | 2021 |
| 33278832 | Thromboembolic and Hemorrhagic Outcomes in the Direct Oral Anticoagulant Trials Across the Spectrum of Kidney Function. | Clin Pharmacol Ther | 2021 |
| 33276038 | Risk Factors for Major Hemorrhage Among Patients Receiving Dabigatran Across the Spectrum of CKD Not Requiring Dialysis Therapy. | Am J Kidney Dis | 2021 |
| 30883405 | Improvement in Kidney Function After Ventricular Assist Device Implantation and Its Influence on Thromboembolism, Hemorrhage, and Mortality. | ASAIO J | 2020 |
| 31786980 | Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study. | Hypertension | 2020 |
| 31869433 | Genetic Factors Influencing Warfarin Dose in Black-African Patients: A Systematic Review and Meta-Analysis. | Clin Pharmacol Ther | 2020 |
| 31664775 | Validation of the Spartan RXCYP2C19 Genotyping Assay Utilizing Blood Samples. | Clin Transl Sci | 2020 |
| 32042096 | Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data. | Pharmacogenomics J | 2020 |
| 33315113 | Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients. | JAMA Netw Open | 2020 |
| 32747766 | Correction: Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection. | Genet Med | 2020 |
| 32678355 | Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection. | Genet Med | 2020 |
| 32363774 | Race-based and sex-based differences in bioactive lipid mediators after myocardial infarction. | ESC Heart Fail | 2020 |
| 32115398 | Residual risk for coronary heart disease events and mortality despite intensive medical management after myocardial infarction. | J Clin Lipidol | 2020 |
| 30506689 | Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals. | Clin Pharmacol Ther | 2019 |
| 31701784 | Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention. | J Am Heart Assoc | 2019 |
| 31691264 | Scalp EEG spikes predict impending epilepsy in TSC infants: A longitudinal observational study. | Epilepsia | 2019 |
| 29855607 | Genome-wide meta-analysis of SNP-by9-ACEI/ARB and SNP-by-thiazide diuretic and effect on serum potassium in cohorts of European and African ancestry. | Pharmacogenomics J | 2019 |
| 31407531 | Genome-wide meta-analysis of SNP and antihypertensive medication interactions on left ventricular traits in African Americans. | Mol Genet Genomic Med | 2019 |
| 31574425 | Racial differences in adult-onset MRI-negative temporal lobe epilepsy. | Epilepsy Behav | 2019 |